Although various clinical scoring systems, such as the Quick Sequential Organ Failure Assessment (qSOFA) (12) and the New York Sepsis Severity Score (13), as well as serum biomarkers including procalcitonin, erythropoietin, and pentraxin-3, are effective for early prognosis assessment in sepsis patients (14), most primary care hospitals lack the capability to measure these biomarkers. Here, PTX3 is linked to Sepsis.